Insider · CIK 0001557533

Ajer Jeffrey Robert

Reports to the SEC for 3 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001557533

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+2,000 sh	—	—	4,277
2026-09-23	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+4,000 sh	—	—	4,000
2026-07-01	VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award	Director	AAward	+32.3K sh	—	—	32,341
2025-09-30	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+8,000 sh	—	—	8,000
2025-07-01	VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	21,000
2025-04-07	VRDNViridian Therapeutics, Inc.\DE · Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2024-09-18	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+120K sh	—	—	120,000
2024-05-02	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−5,000 sh	$82.91	−$415K	66,767
2024-04-30	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+300 sh	$68.65	+$20.6K	71,767
2024-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−22.6K sh	$83.87	−$1.89M	71,467
2024-03-05	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−4,000 sh	$87.07	−$348K	94,047
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+9,338 sh	—	—	91,582
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+6,465 sh	—	—	98,047
2024-02-27	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+21.4K sh	—	—	82,244
2023-09-19	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+85K sh	—	—	85,000
2023-09-18	NKTRNEKTAR THERAPEUTICSS Sale	Director	SSale	−4,359 sh	$0.69	−$3,007.71	34,153
2023-08-16	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−5,000 sh	$90.00	−$450K	60,804
2023-04-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+318 sh	$66.88	+$21.3K	65,804
2023-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−20.5K sh	$93.41	−$1.92M	65,486
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−3,971 sh	$87.74	−$348K	85,996
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+10.1K sh	—	—	89,967
2023-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	EVP, Chief Commercial Officer	AAward	+23.1K sh	—	—	23,070
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+20.8K sh	—	—	61,848
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+7,629 sh	—	—	79,857
2023-02-28	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+10.4K sh	—	—	72,228
2023-01-25	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−4,175 sh	$116.15	−$485K	41,088
2023-01-25	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+49K sh	$67.81	+$3.32M	90,088
2023-01-25	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−44.8K sh	$115.65	−$5.18M	45,263
2023-01-25	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−2,200 sh	—	—	0
2023-01-25	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−46.8K sh	—	—	0
2022-11-02	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−3,000 sh	$86.12	−$258K	41,088
2022-09-23	NKTRNEKTAR THERAPEUTICSS Sale	Director	SSale	−4,198 sh	$3.16	−$13.3K	38,512
2022-09-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+20.4K sh	—	—	20,400
2022-09-16	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+10.2K sh	—	—	42,710
2022-08-11	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−3,000 sh	$95.62	−$287K	44,088
2022-06-03	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−7,021 sh	$77.49	−$544K	47,088
2022-05-26	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−1,308 sh	$78.94	−$103K	54,109
2022-04-29	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+340 sh	$62.41	+$21.2K	55,417
2022-04-13	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−1,180 sh	$82.47	−$97.3K	55,077
2022-03-30	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−1,381 sh	$79.56	−$110K	56,257
2022-03-29	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−1,618 sh	$79.43	−$129K	57,638
2022-03-23	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−6,129 sh	$81.78	−$501K	59,256
2022-03-22	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−2,073 sh	$81.00	−$168K	65,385
2022-03-16	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−1,287 sh	$80.72	−$104K	67,458
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)A Award	EVP, Chief Commercial Officer	AAward	+28.7K sh	—	—	28,670
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−8,418 sh	$78.27	−$659K	68,745
2022-03-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+11.9K sh	—	—	77,163
2022-03-08	BMRNBIOMARIN PHARMACEUTICAL INCA Award	EVP, Chief Commercial Officer	AAward	+9,370 sh	—	—	65,223
2021-10-26	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	EVP, Chief Commercial Officer	SSale	−2,739 sh	$73.60	−$202K	55,853
2021-09-22	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+10.2K sh	—	—	36,175

Recent filings

Accepted (ET)
Sep 254
Ajer Jeffrey Robert0001193125-26-403097
SEC(opens sec.gov)
Jul 24
Ajer Jeffrey Robert0001193125-26-294560
SEC(opens sec.gov)
Oct 14
Ajer Jeffrey Robert0001193125-25-227232
SEC(opens sec.gov)
Jul 24
Ajer Jeffrey Robert0000950170-25-093102
SEC(opens sec.gov)
Apr 94
Ajer Jeffrey Robert0000950170-25-052530
SEC(opens sec.gov)
Jan 175
Ajer Jeffrey Robert0000950170-25-006880
SEC(opens sec.gov)
May 64
Ajer Jeffrey Robert0001048477-24-000073
SEC(opens sec.gov)
Mar 194
Ajer Jeffrey Robert0001048477-24-000036
SEC(opens sec.gov)
Mar 74
Ajer Jeffrey Robert0001048477-24-000030
SEC(opens sec.gov)
Feb 294
Ajer Jeffrey Robert0001048477-24-000022
SEC(opens sec.gov)
Sep 204
Ajer Jeffrey Robert0001209191-23-050220
SEC(opens sec.gov)
Aug 174
Ajer Jeffrey Robert0001048477-23-000039
SEC(opens sec.gov)
Mar 174
Ajer Jeffrey Robert0001567619-23-005283
SEC(opens sec.gov)

Companies

Address

C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH

SAN FRANCISCO, CA, 94158